Sirvi Autor "Haurilyiuk, Vasili" järgi

Nüüd näidatakse 1 - 2 2

listelement.badge.access-status Avatud juurdepääs ,
A hyperpromiscuous antitoxin protein domain for the neutralization of diverse toxin domains
(PNAS, 2022-02-04) kurata, Tatsuki; Saha, Chayan Kumar; Buttress, Jessica A.; Mets, Toomas; Brodiazhenko, Tetiana; Turnbull, Kathrin J; Awoyomi, Ololade F.; Oliveira, Sofia Raquel Alves; Jimmy, Steffi; Ernits, Karin; Delannoy, Maxence; Persson, Karina; Tenson, Tanel; Strahl, Henrik; Haurilyiuk, Vasili; Atkinson, Gemma C
Toxin–antitoxin (TA) gene pairs are ubiquitous in microbial chromosomal genomes and plasmids as well as temperate bacteriophages. They act as regulatory switches, with the toxin limiting the growth of bacteria and archaea by compromising diverse essential cellular targets and the antitoxin counteracting the toxic effect. To uncover previously uncharted TA diversity across microbes and bacteriophages, we analyzed the conservation of genomic neighborhoods using our computational tool FlaGs (for flanking genes), which allows high-throughput detection of TA-like operons. Focusing on the widespread but poorly experimentally characterized antitoxin domain DUF4065, our in silico analyses indicated that DUF4065-containing proteins serve as broadly distributed antitoxin components in putative TA-like operons with dozens of different toxic domains with multiple different folds. Given the versatility of DUF4065, we have named the domain Panacea (and proteins containing the domain, PanA) after the Greek goddess of universal remedy. We have experimentally validated nine PanA-neutralized TA pairs. While the majority of validated PanA-neutralized toxins act as translation inhibitors or membrane disruptors, a putative nucleotide cyclase toxin from a Burkholderia prophage compromises transcription and translation as well as inducing RelA-dependent accumulation of the nucleotide alarmone (p)ppGpp. We find that Panacea-containing antitoxins form a complex with their diverse cognate toxins, characteristic of the direct neutralization mechanisms employed by Type II TA systems. Finally, through directed evolution, we have selected PanA variants that can neutralize noncognate TA toxins, thus experimentally demonstrating the evolutionary plasticity of this hyperpromiscuous antitoxin domain.
listelement.badge.access-status Avatud juurdepääs ,
RelA-SpoT Homolog toxins pyrophosphorylate the CCA end of tRNA to inhibit protein synthesis
(Cell Press, 2021-08) Brodiazhenko, Tetiana; Alves Oliveira, Sofia Raquel; Roghanian, Mohammad; Sakaguchi, Yuriko; Turnbull, Kathryn Jane; Bulvas, Ondrej; Takada, Hiraku; Tamman, Hedvig; Ainelo, Andres; Pohl, Radek; Rejman, Dominik; Tenson, Tanel; Suzuki, Tsutomu; Garcia-Pino, Abel; Atkinson, Gemma C; Haurilyiuk, Vasili; Kurata, Tatsuki
RelA-SpoT Homolog (RSH) enzymes control bacterial physiology through synthesis and degradation of the nucleotide alarmone (p)ppGpp. We recently discovered multiple families of small alarmone synthetase (SAS) RSH acting as toxins of toxin-antitoxin (TA) modules, with the FaRel subfamily of toxSAS abrogating bacterial growth by producing an analog of (p)ppGpp, (pp)pApp. Here we probe the mechanism of growth arrest used by four experimentally unexplored subfamilies of toxSAS: FaRel2, PhRel, PhRel2, and CapRel. Surprisingly, all these toxins specifically inhibit protein synthesis. To do so, they transfer a pyrophosphate moiety from ATP to the tRNA 3′ CCA. The modification inhibits both tRNA aminoacylation and the sensing of cellular amino acid starvation by the ribosome-associated RSH RelA. Conversely, we show that some small alarmone hydrolase (SAH) RSH enzymes can reverse the pyrophosphorylation of tRNA to counter the growth inhibition by toxSAS. Collectively, we establish RSHs as RNA-modifying enzymes.